Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00932139 · ClinicalTrials.gov registry record · NA

Effect of Electro-Acupuncture on Blood Pressure

A NA study of Hypertension, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
2
Study locations

NCT00932139: Recruiting NA study of Hypertension, sponsored by University of California, Irvine.

NCT00932139 is a NA study of Hypertension that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 160 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00932139, a NA study of Hypertension, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
2
Study locations

Study Summary

Based on previous published research in animals and human, the investigators hypothesize that electroacupuncture (EA) will have a positive effect on hypertension.

Primary Outcome

evaluation of systolic and diastolic blood pressures changes

Conditions Studied

Interventions

  • PROCEDURE Electro-acupuncture control
  • PROCEDURE Electro-acupuncture test

Study Locations (2)

California

  • Susan Samueli Integrative Health Institute - Irvine
  • UCIMedical Center - Orange

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2003-02
Est. Completion 2027-12
Phase NA
University of California, Irvine

368 total trials

What NCT00932139 shows while recruiting

NCT00932139 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Electro-acupuncture control is the first listed.

NCT00932139 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00932139 about?

NCT00932139 is a clinical study titled "Effect of Electro-Acupuncture on Blood Pressure". Based on previous published research in animals and human, the investigators hypothesize that electroacupuncture (EA) will have a positive effect on hypertension.

What is the current status of trial NCT00932139?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2003-02. Estimated completion is 2027-12.

What conditions does trial NCT00932139 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00932139?

The interventions under investigation include: Electro-acupuncture control (PROCEDURE), Electro-acupuncture test (PROCEDURE).

Who is sponsoring clinical trial NCT00932139?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00932139 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00932139's enrollment target sits among peer trials

160 238th of 470 higher than 228 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

  • NCT02193841 · 160 participants · Phase 3

    Simple Bone Cysts in Kids

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00932139, the US trial registry maintained by the National Library of Medicine. NCT00932139 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.